Home » Authors » Karen Young

Articles by Karen Young

Chemokine Therapeutics Focuses Effort On Cytokines, Chemokines

May 27, 2003

Chemokine Therapeutics Focuses Effort On Cytokines, Chemokines

May 27, 2003

Blue Heron Making Waves With Products For Gene Synthesis

May 13, 2003

Blue Heron Making Waves With Products For Gene Synthesis

May 13, 2003

Abeome Adds To Seed Round To Advance Work In Antibodies

April 15, 2003

Abeome Adds To Seed Round To Advance Work In Antibodies

April 15, 2003

Hemosol Laying Off All Staff As It Searches For Path Forward

April 8, 2003

Hemosol Laying Off All Staff As It Searches For Path Forward

April 8, 2003

Juvaris Planning Growth With Immune-Stimulating Platform

March 21, 2003

Juvaris Planning Growth With Immune-Stimulating Platform

March 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.